Literature DB >> 15986424

In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage.

Luigi Zecca1, Daniela Berg, Thomas Arzberger, Petra Ruprecht, Wolf D Rausch, Massimo Musicco, Davide Tampellini, Peter Riederer, Manfred Gerlach, Georg Becker.   

Abstract

Early diagnosis of Parkinson's disease (PD) in nonsymptomatic patients is a key issue. An increased echogenicity of the substantia nigra (SN) was found previously in Parkinsonian patients and in a low percentage of healthy adults. These nonsymptomatic subjects also showed a reduced 18F-dopa uptake in striatum, suggesting a preclinical injury of the nigrostriatal system that could later proceed into PD. To investigate the ability of ultrasonography to detect markers of SN degeneration, such as iron deposition and neuromelanin depletion, we scanned postmortem brains from normal subjects at different ages by ultrasound and measured the echogenic area of the SN. The SN was then dissected and used for histological examinations and determination of iron, ferritin, and neuromelanin content. A significant positive correlation was found between the echogenic area of the SN and the concentration of iron, H- and L-ferritins. Multivariate analysis carried out considering the iron content showed a significant negative correlation between echogenicity and neuromelanin content of the SN. In PD, a typical loss of neuromelanin and increase of iron is observed in this brain area. The finding of a positive correlation between iron and ferritin levels and a negative correlation of neuromelanin content with the area of echogenicity at the SN could therefore provide an interesting basis for diagnosis and therapeutic follow-up studies in PD. Copyright (c) 2005 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15986424     DOI: 10.1002/mds.20550

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  61 in total

1.  Restless legs and substantia nigra hypoechogenicity are common features in Friedreich's ataxia.

Authors:  Matthis Synofzik; Jana Godau; Tobias Lindig; Ludger Schöls; Daniela Berg
Journal:  Cerebellum       Date:  2011-03       Impact factor: 3.847

2.  Dose- and time-dependent alpha-synuclein aggregation induced by ferric iron in SK-N-SH cells.

Authors:  Wen-Jing Li; Hong Jiang; Ning Song; Jun-Xia Xie
Journal:  Neurosci Bull       Date:  2010-06       Impact factor: 5.203

3.  Using high-resolution MR imaging at 7T to evaluate the anatomy of the midbrain dopaminergic system.

Authors:  M Eapen; D H Zald; J C Gatenby; Z Ding; J C Gore
Journal:  AJNR Am J Neuroradiol       Date:  2010-12-23       Impact factor: 3.825

Review 4.  Early diagnosis of Parkinson's disease.

Authors:  Jörg Spiegel; Alexander Storch; Wolfgang H Jost
Journal:  J Neurol       Date:  2006-08       Impact factor: 4.849

5.  In vivo detection of iron and neuromelanin by transcranial sonography--a new approach for early detection of substantia nigra damage.

Authors:  D Berg
Journal:  J Neural Transm (Vienna)       Date:  2006-05-18       Impact factor: 3.575

Review 6.  Genetics of iron regulation and the possible role of iron in Parkinson's disease.

Authors:  Shannon L Rhodes; Beate Ritz
Journal:  Neurobiol Dis       Date:  2008-07-11       Impact factor: 5.996

7.  Transcranial sonography in movement disorders: an interesting tool for diagnostic perspectives.

Authors:  E Sanzaro; F Iemolo
Journal:  Neurol Sci       Date:  2015-12-09       Impact factor: 3.307

8.  Transcranial sonography image characteristics in different Parkinson's disease subtypes.

Authors:  Ai Yan Sheng; Ying Chun Zhang; Yu Jing Sheng; Cai Shan Wang; Ying Zhang; Hua Hu; Wei Feng Luo; CHun-Feng LIu
Journal:  Neurol Sci       Date:  2017-07-19       Impact factor: 3.307

9.  Restoration of nigrostriatal dopamine neurons in post-MPTP treatment by the novel multifunctional brain-permeable iron chelator-monoamine oxidase inhibitor drug, M30.

Authors:  Shunit Gal; Hailin Zheng; Mati Fridkin; Moussa B H Youdim
Journal:  Neurotox Res       Date:  2009-07-16       Impact factor: 3.911

10.  Transcranial sonography and functional imaging in glucocerebrosidase mutation Parkinson disease.

Authors:  M J Barrett; J Hagenah; V Dhawan; S Peng; K Stanley; D Raymond; A Deik; S J Gross; N Schreiber-Agus; A Mirelman; K Marder; L J Ozelius; D Eidelberg; S B Bressman; R Saunders-Pullman
Journal:  Parkinsonism Relat Disord       Date:  2012-10-10       Impact factor: 4.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.